Pertussis Medications and Vaccinations Leading Therapeutic
Approaches Driving Stance of Companies in the Market.
ROCKVILLE, Md., July 31, 2024 /PRNewswire/ -- The global
Pertussis Treatment Market is estimated at a value of
US$ 3.8 billion in 2024 and is
forecasted to increase to US$ 5.3
billion by the end of 2034, reveals Fact.MR, a market
research and competitive intelligence provider, in its new research
report.
Pertussis, also known as whooping cough, is an infectious
respiratory disease caused by the Bordetella pertussis bacteria.
Pertussis mostly affects young children and the older population,
and treatment involves medication, vaccination, and supportive
care.
Rising prevalence of whooping cough caused by different factors
is leading to a high demand for innovative and effective pertussis
therapeutic solutions. Drug manufacturers are focused on developing
new antibiotics and treatment protocols to combat Bordetella
pertussis bacteria. For the same, industry giants are heavily
investing in research and development efforts. Targeted antibiotic
therapies are the frontline treatments for pertussis infection.
Researchers worldwide are also exploring novel antibiotic
classes that can demonstrate efficacy against the Bordetella
pertussis bacteria. Combination therapies are expected to offer
enhanced treatment outcomes and reduce the likelihood of
resistance. Furthermore, the personalized medication trend is also
set to offer lucrative growth opportunities for key companies that
are involved in providing pertussis treatment solutions.
For More Insights into the Market, Request a Sample of this
Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10267
Key Takeaways from the Pertussis Treatment Market
Study:
- Global demand for pertussis therapeutic solutions is projected
to rise at a CAGR of 3.4 from 2024 to 2034.
- The market for pertussis treatment in the United States is forecasted at a value of
US$ 1.29 billion in 2024.
- Sales of pertussis drugs in South
Korea are forecasted to rise at a CAGR of 3.7% through
2034.
- The market for pertussis medications is estimated at
US$ 1.59 billion in 2024.
- Hospital pharmacies are projected to capture 39.1% of the
global market share by 2034.
"North America, followed
by Western Europe, will be key
regional markets for pertussis treatment over the next
decade," says a Fact.MR analyst.
Leading Players Driving Innovation in
the Pertussis Treatment Market:
Key participants in the pertussis treatment industry are Johnson
& Johnson Services Inc.; GlaxoSmithKline, Plc.; Merck & Co.
Inc.; Sanofi; Pfizer Inc.; Novartis AG; Panacea Biotech; China
National Biotec Group; Changchun Changsheng Life Sciences; Daiichi
Sankyo Company Ltd.; Mylan NV; Boehringer Ingelheim International
GmbH; Bristol Myers Squibb Company; Mitsubishi Tanabe Pharma;
Astellas Pharma; Shenzhen KangTai Biological Products.
Collaborations Key Trend in the Pertussis Treatment
Market:
Pharmaceutical companies, research institutions, and government
healthcare organizations are collaborating for the development and
discovery of advanced pertussis medications. These collaborations
are aimed at becoming more effective in reducing the ill effects of
pertussis and boosting the profits of several stakeholders.
International agreements are aimed at the more effective addressing
and managing of pertussis globally. These are expected to increase
the sales of pertussis therapeutic solutions, especially in
high-potential markets such as Latin
America and Asia
Pacific.
According to an article under scientific reports published by
Nature on 16th March 2023, a
pangenome approach-based loop-mediated isothermal amplification
assay is proving effective for specific and early detection of
pertussis infection.
Pertussis Treatment Industry News:
On 25 March 2024, As per a press
release by EurekAlert, researchers from the American Society for
Biochemistry and Molecular Biology uncovered a key biomolecule
involved in pertussis infection. The discovery is expected to aid
in creating a new drug or vaccine for whooping cough.
Get Customization on this Report for Specific Research
Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10267
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Type:
- Medications
- Vaccinations
- Supportive Treatments
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Diagnosis:
- Blood Tests
- Chest X-Rays
- Nose or Throat Culture & Tests
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Mode of Purchase:
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Route of Administration:
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Global Market Analysis 2019 to 2023 and Forecast 2024 to
2034, by Disease Stage:
- Incubation Stage
- Catarrhal Stage
- Paroxysmal Stage
- Convalescent Stage
More Valuable Insights:
Fact.MR, in its new offering, presents an unbiased analysis of
the global pertussis treatment market, presenting historical
demand data (2019 to 2023) and forecast statistics for the period
(2024 to 2034).
The study divulges essential insights on the market-based
treatment type (medications, vaccinations, supportive treatments,
others), diagnosis (blood tests, chest X-rays, nose or throat
culture & tests), mode of purchase (Rx, OTC), route of
administration (oral, parenteral, others), disease stage
(incubation stage, catarrhal stage, paroxysmal stage, convalescent
stage), and distribution channel (hospital pharmacies, online
pharmacies, retail pharmacies), across seven major regions of the
world (North America, Latin America, Western Europe, Eastern Europe, East
Asia, South Asia &
Pacific, and MEA).
Check out More Related Studies Published by Fact.MR
Research:
Psychotic Disorder Treatment Market accounts for
US$ 13.6 billion and is projected to
surge past a valuation of US$ 24.5
billion by the end of 2032.
Alexandrite Laser Treatment Market is calculated at
US$ 48.7 million for 2024 and is
forecasted to reach US$ 83.2 million
by 2034, advancing at a CAGR of 5.5%.
Achalasia Treatment Market Statistics by Treatment
(Non-Surgical Treatment, Botulinum Toxin Type A, Pneumatic
Dilation, Surgical Treatment, Peroral Endoscopic Myotomy (POEM),
Heller Myotomy) & By End User- Global Review 2018 To 2028.
Lewy Body Dementia Treatment Market is predicted to expand
steadily at 6% CAGR and reach US$ 8.45
billion by the end of 2033.
Antibiotic-Associated Diarrhea Treatment Market Forecast,
Trend Analysis & Competition Tracking - Global Review 2018 to
2028
Bell's Palsy Treatment Market by Drug Class
(Corticosteroids, Anticonvulsants, Antibacterial, Antivirals),
Based on Distribution Channel (Hospital, Retail, Drug Stores,
Online) - Global Insights to 2028.
About Us:
Fact.MR is a distinguished market research company
renowned for its comprehensive market reports and invaluable
business insights. As a prominent player in business intelligence,
we deliver deep analysis, uncovering market trends, growth paths,
and competitive landscapes. Renowned for its commitment to accuracy
and reliability, we empower businesses with crucial data and
strategic recommendations, facilitating informed decision-making
and enhancing market positioning.
With its unwavering dedication to providing reliable market
intelligence, FACT.MR continues to assist companies in navigating
dynamic market challenges with confidence and achieving long-term
success. With a global presence and a team of experienced analysts,
FACT.MR ensures its clients receive actionable insights to
capitalize on emerging opportunities and stay ahead in the
competitive landscape.
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
View original
content:https://www.prnewswire.co.uk/news-releases/pertussis-treatment-market-projected-to-hit-us-5-3-billion-by-2034--with-a-3-4-cagr--factmr-report-302209937.html